UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023956 |
|---|---|
| Receipt number | R000027581 |
| Scientific Title | Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed intermediate rhabdomyosarcoma. |
| Date of disclosure of the study information | 2016/10/01 |
| Last modified on | 2020/03/11 09:26:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/09/06 18:06:20 | ||
| 2 | Update | 2017/03/08 11:08:14 | Anticipated trial start date |
|
| 3 | Update | 2017/09/07 15:54:25 | Recruitment status |
|
| 4 | Update | 2020/03/11 09:26:16 | Date of IRB Last follow-up date |
